Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
2007802 citationsAnne E. Fung, Geeta A. Lalwani et al.American Journal of Ophthalmologyprofile →
A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
2009719 citationsGeeta A. Lalwani, Philip J. Rosenfeld et al.American Journal of Ophthalmologyprofile →
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide
2006446 citationsAnne E. Fung, Philip J. Rosenfeld et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Anne E. Fung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Fung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Fung more than expected).
This network shows the impact of papers produced by Anne E. Fung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Fung. The network helps show where Anne E. Fung may publish in the future.
Co-authorship network of co-authors of Anne E. Fung
This figure shows the co-authorship network connecting the top 25 collaborators of Anne E. Fung.
A scholar is included among the top collaborators of Anne E. Fung based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Anne E. Fung. Anne E. Fung is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Frenkel, R. E. P., Anne E. Fung, Howard Shapiro, & Ivaylo Stoilov. (2015). Low luminance vision improves nearly twice as much as standard vision with ranibizumab for neovascular age-related macular degeneration. Investigative Ophthalmology & Visual Science. 56(7). 5358–5358.1 indexed citations
7.
MacKeben, Manfred, et al.. (2012). Effects Of Ranibizumab Injections On Functional Vision In Advanced Amd. Investigative Ophthalmology & Visual Science. 53(14). 4395–4395.2 indexed citations
Fung, Anne E., et al.. (2009). Myocardial Infarction and Cerebrovascular Accident in Patients With Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 50(13). 4423–4423.1 indexed citations
London, Nikolas & Anne E. Fung. (2008). Evaluating the Nerve and Macular Thickness Measurements of the Optovue RTVue, Zeiss Stratus, and Cirrus OCTs. Investigative Ophthalmology & Visual Science. 49(13). 4241–4241.1 indexed citations
Lalwani, Geeta A., Anne E. Fung, Stephan Michels, et al.. (2007). An OCT-Guided Variable-Dosing Regimen With Ranibizumab (Lucentis) in Neovascular AMD: Two Year Results of the PrONTO Study. Investigative Ophthalmology & Visual Science. 48(13). 1834–1834.2 indexed citations
15.
Fung, Anne E., Geeta A. Lalwani, Stephan Michels, et al.. (2007). Characteristics of Patients Losing Vision at Year 1 of the PrONTO Study. Investigative Ophthalmology & Visual Science. 48(13). 4579–4579.1 indexed citations
16.
Fung, Anne E., Geeta A. Lalwani, Philip J. Rosenfeld, et al.. (2007). An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration. American Journal of Ophthalmology. 143(4). 566–583.e2.802 indexed citations breakdown →
17.
Fung, Anne E., et al.. (2006). Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study. Investigative Ophthalmology & Visual Science. 47(13). 2958–2958.11 indexed citations
18.
Fung, Anne E., et al.. (2006). Intravitreal Avastin Safety Survey: Results From the World Wide Web. Investigative Ophthalmology & Visual Science. 47(13). 5251–5251.3 indexed citations
Rosenfeld, Philip J., Carmen A. Puliafito, Stephan Michels, et al.. (2005). Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration (SANA) Study: Visual Acuity Outcomes. Investigative Ophthalmology & Visual Science. 46(13). 2310–2310.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.